Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Benralizumab placebo
DRUG
2 trials
Sponsors
AstraZeneca
, Temple University
Conditions
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Phase 2
Immunological Basis for Benralizumab Activity in Chronic Obstructive Pulmonary Disease (COPD)
NCT05273359
Temple University
Chronic Obstructive Pulmonary Disease (COPD)
Start: 2023-04-30
End: 2025-01-31
Target: 45
Updated: 2023-04-07
Phase 3
Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma
Completed
NCT02814643
AstraZeneca
Asthma
Start: 2016-07-01
End: 2017-01-24
Updated: 2018-10-24
Related Papers
Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial.
2018-11-20
30 citations